跳至主要内容
临床试验/CTRI/2024/07/070704
CTRI/2024/07/070704尚未招募4 期

Comprehensive Assessment of CEREBO to evaluate its clinical performance, utility and Usability in the Brain Injury Management

Indian Council of Medical Research1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2024年7月26日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
134
试验地点
1
主要终点
Assessing the utility of CEREBO in reducing the mean transfer time from injury to treatment

研究概览

简要总结

This clinical study aims to assess the effectiveness of the CEREBO device in decreasing the mean time from injury to treatment by comparing outcomes between a control group and an experimental group. In cases of traumatic brain injury (TBI), timely intervention is crucial. The study will specifically evaluate CEREBO’s impact on operational efficiency, focusing on its ability to reduce the mean time from the initial point of injury to the CT scan and thus the treatment. This analysis will help determine if the integration of CEREBO into standard care protocols can expedite treatment and potentially improve outcomes for TBI patients.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant and Investigator Blinded

入排标准

年龄范围
0.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • •Patients with head injury referred for head CT/MRI scan.

排除标准

  • •Patients with scalp bruises or hematoma.

结局指标

主要结局

Assessing the utility of CEREBO in reducing the mean transfer time from injury to treatment

时间窗: 3 years

次要结局

  • To assess the usability among healthcare professionals & operators & identify areas of improvement for specific use cases(3 years)

研究者

申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Zahir Quazi

Datta Meghe Institute of Higher Education & Research

研究点 (1)

Loading locations...

相似试验